APOC3 and hypertriglyceridemia: ApoCIII is an 8.8 kDa polypeptide synthesized by the liver and playing an important role in controlling catabolism of triglyceride-rich lipoproteins by inhibiting the activity of lipoprotein lipase thereby inducing hypertriglyceridemia [21,22].